35 years of research leads to estrogen-DNA breakthrough
Every 13 minutes a woman loses her battle with breast cancer and in 2009 alone more than 27,000 men died from prostate cancer. These powerful statistics continue to fuel research and new developments. With tens of millions of dollars in financial support from the National Cancer Institute and the U.S. Department of Defense, scientists have identified when estrogen metabolism is out of balance it can start the process leading to breast cell mutations. In partnership with the scientists, Prevennia- is a new dietary supplement, scientifically-proven and supported by 35 years of research, designed to block the triggering mechanism that can cause breast cell mutations.
Research has shown that when the body's estrogen metabolism is unbalanced, the estrogen metabolites can react with DNA and thereby are prone to start the process leading to mutations in cells. Renowned scientists Dr. Ercole Cavalieri and Dr. Eleanor Rogan, who have been involved with these scientific findings and research for more than three decades, have published their findings in the following journals: International Journal of Cancer; Cancer Prevention Research; Breast Cancer: Basic and Clinical Research; Prostate; Journal of Steroid Biochemistry and Molecular Biology; Future Oncology.